Scarica l'app Stockscreener
1.73
1.17%
0.02
Dopo l'orario di chiusura:
1.70
-0.03
-1.73%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Essa Pharma Inc Borsa (EPIX) Ultime notizie
Class Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery for Investors – Contact Levi & Korsinsky - GlobeNewswire
EPIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your RightsEPIX - PR Newswire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
EPIX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit - PR Newswire
ESSA ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
EPIX Investor Notice: Shareholder Rights Law Firm Robbins - GlobeNewswire
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Malaysian Reserve
Stockholder Alert: Robbins LLP Informs Investors of the ESS Pharma Inc. Class Action - cnhinews.com
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
EPIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
ESSA Pharma Misled Investors Over Cancer Treatment, Lawsuit Says - Bloomberg Law
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against ESSA Pharma Inc. (EPIX) - EIN News
Rosen Law Firm Urges ESSA Pharma Inc. (NASDAQ: EPIX) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire
Short Interest in ESSA Pharma Inc. (NASDAQ:EPIX) Declines By 5.3% - MarketBeat
ESSA Pharma (NASDAQ:EPIX) Share Price Passes Below 50 Day Moving AverageTime to Sell? - MarketBeat
3 Promising US Penny Stocks With Market Caps Under $80M - Simply Wall St
ESSA Pharma Inc. (NASDAQ:EPIX) Sees Significant Growth in Short Interest - MarketBeat
ESSA Pharma (NASDAQ:EPIX) Stock Price Passes Below 50 Day Moving Average – What’s Next? - Defense World
ESSA Pharma (NASDAQ:EPIX) Stock Price Passes Below 50 Day Moving AverageWhat's Next? - MarketBeat
Surprising News! ESSA Pharma’s Big Breakthrough Expected Soon. - Jomfruland.net
When Will ESSA Pharma Inc. (NASDAQ:EPIX) Turn A Profit? - Yahoo Finance
ESSA Pharma’s Cash Management: A Potential Risk to Shareholder Value and Market Stability - TipRanks
ESSA Pharma Inc. Reports Strategic Shift Amid Losses - TipRanks
ESSA Pharma: Fiscal Q4 Earnings Snapshot - The Ridgefield Press
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 - Barchart
ESSA Pharma Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024 - Marketscreener.com
ESSA Pharma (NASDAQ:EPIX) Issues Earnings Results - MarketBeat
SEC Form 10-K filed by ESSA Pharma Inc. - Quantisnow
ESSA Pharma Halts Key Cancer Drug Trials, Initiates Strategic Review Amid Clinical Setback - StockTitan
ESSA Pharma ends long-standing license agreement with cancer agencies - Investing.com
ESSA Pharma Inc. Adopts Executive Severance Plan**United States Securities and Exchange Commission Filing – ESSA Pharma Inc. submitted a current report on Form 8-K, dated June 5, 2024, announcing the adoption of the ESSA Pharma Inc. Severance P - Defense World
ESSA Pharma Introduces New Executive Severance Plan - TipRanks
RTW Investments LP Grows Stake in ESSA Pharma Inc. (NASDAQ:EPIX) - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc.EPIX - PR Newswire
Applied Digital, ESSA Pharma And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session - MSN
Piper Sandler Downgrades ESSA Pharma (EPIX) - MSN
United States shares higher at close of trade; Dow Jones Industrial Average up 0.69% - MSN
Thinking about buying stock in Adverum Biotechnologies, Roma Gre - GuruFocus.com
Oppenheimer Downgrades ESSA Pharma (EPIX) - MSN
5.49%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):